
Sharon X. Wen
Examiner (ID: 11379, Phone: (571)270-3064 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1609, 1644, 1641 |
| Total Applications | 952 |
| Issued Applications | 502 |
| Pending Applications | 90 |
| Abandoned Applications | 383 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19473880
[patent_doc_number] => 12103956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Suicide module compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/270827
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18734
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270827 | Suicide module compositions and methods | Sep 29, 2019 | Issued |
Array
(
[id] => 15993523
[patent_doc_number] => 20200172632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES
[patent_app_type] => utility
[patent_app_number] => 16/585805
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585805 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES | Sep 26, 2019 | Abandoned |
Array
(
[id] => 15678393
[patent_doc_number] => 20200093860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => ANTIGEN BINDING RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/576546
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/576546 | Antigen binding receptors specific for mutated Fc domains | Sep 18, 2019 | Issued |
Array
(
[id] => 15866335
[patent_doc_number] => 20200140571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
[patent_app_type] => utility
[patent_app_number] => 16/570591
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570591 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES | Sep 12, 2019 | Abandoned |
Array
(
[id] => 17875571
[patent_doc_number] => 11447572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Anti-ceramide antibodies
[patent_app_type] => utility
[patent_app_number] => 16/568152
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 11832
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16568152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/568152 | Anti-ceramide antibodies | Sep 10, 2019 | Issued |
Array
(
[id] => 15296029
[patent_doc_number] => 20190391150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/566273
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/566273 | COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES | Sep 9, 2019 | Abandoned |
Array
(
[id] => 18434464
[patent_doc_number] => 20230181758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/271176
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271176 | EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF | Aug 22, 2019 | Abandoned |
Array
(
[id] => 15915421
[patent_doc_number] => 10654940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Method for treating joint damage
[patent_app_type] => utility
[patent_app_number] => 16/526727
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 49
[patent_no_of_words] => 51468
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526727 | Method for treating joint damage | Jul 29, 2019 | Issued |
| 16/475876 | Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15363675
[patent_doc_number] => 20200017602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => PLASMA KALLIKREIN BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/445304
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445304 | Nucleic acids encoding plasma kallikrein binding proteins | Jun 18, 2019 | Issued |
Array
(
[id] => 16779367
[patent_doc_number] => 20210116445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHOD FOR SEPARATING ANTIBODY, AND METHOD FOR TESTING ON DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/253824
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253824 | Method for separating antibody, and method for testing on disease | Jun 17, 2019 | Issued |
Array
(
[id] => 15408085
[patent_doc_number] => 20200024364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/415837
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415837 | DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS | May 16, 2019 | Abandoned |
Array
(
[id] => 18013338
[patent_doc_number] => 11505620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Methods of detecting plasma kallikrein
[patent_app_type] => utility
[patent_app_number] => 16/411242
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 67842
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1572
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411242 | Methods of detecting plasma kallikrein | May 13, 2019 | Issued |
Array
(
[id] => 16500006
[patent_doc_number] => 10865382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Reducing immune tolerance induced by PD-L1
[patent_app_type] => utility
[patent_app_number] => 16/404349
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13859
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404349 | Reducing immune tolerance induced by PD-L1 | May 5, 2019 | Issued |
Array
(
[id] => 17206660
[patent_doc_number] => 11167011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Methods for treating bone loss using sclerostin peptides
[patent_app_type] => utility
[patent_app_number] => 16/396896
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20607
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396896 | Methods for treating bone loss using sclerostin peptides | Apr 28, 2019 | Issued |
Array
(
[id] => 15008527
[patent_doc_number] => 10450379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Method for treating joint damage
[patent_app_type] => utility
[patent_app_number] => 16/384333
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 49
[patent_no_of_words] => 51518
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384333 | Method for treating joint damage | Apr 14, 2019 | Issued |
Array
(
[id] => 15038733
[patent_doc_number] => 20190330371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations
[patent_app_type] => utility
[patent_app_number] => 16/367795
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367795
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/367795 | Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations | Mar 27, 2019 | Abandoned |
Array
(
[id] => 15206403
[patent_doc_number] => 20190365888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS
[patent_app_type] => utility
[patent_app_number] => 16/363836
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363836 | COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS | Mar 24, 2019 | Abandoned |
Array
(
[id] => 15408089
[patent_doc_number] => 20200024366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
[patent_app_type] => utility
[patent_app_number] => 16/296852
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/296852 | ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING | Mar 7, 2019 | Abandoned |
Array
(
[id] => 15293665
[patent_doc_number] => 20190389968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => ANTI-PCSK9 ANTIBODIES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/294085
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 147424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294085 | ANTI-PCSK9 ANTIBODIES AND USE THEREOF | Mar 5, 2019 | Abandoned |